Avicenna Day 2022 Programme

Tuesday 15 February 2022

Time: 14.00 – 18:30 CEST / 13.00 - 17.30 BST / 17.30 - 22.00 IST / 8.00 - 12.30 EDT / 7.00 - 11.30 CDT

 

14:00 - 14:05          Welcome

                                   Roberta Maggi, Office Manager, Avicenna Alliance

14:05 - 14:20          Introduction to Avicenna Alliance

                                 Thierry Marchal, Secretary General, Avicenna Alliance

    

14:20 - 14:50          The Vision

                                 Randy Schiestl, Boston Scientific

                                 Blanca Rodriguez, University of Oxford

                                 Prasanna Pathmanathan, FDA

    

14:50 - 15:30         The Achievements

                                 Nele Famaey, KU Leuven, Chair of Tissue Characterization Task Force

                                 Engaging with Notified Bodies and other European Stakeholders, Simon Sonntag, Virtonomy, Chair of Notified Bodies Task Force

                                 Mark Horner, Ansys, Chair of Global Harmonization Task Force

    

 15:30 - 15:45         BREAK

    

 15:45 - 17:15         From a Technology Dream to a Regulatory Routine: an Ongoing, Successful Journey

                                Learning from USA, sharing with the world, Mark Palmer, Medtronic, Leader of the International Affairs Working Group and the

                                International Affairs team;

                                Adoption of in silico methods for European Regulatory Activities, Emmanuelle Voisin, VCLS, Leader of the Policy Development

                                 Working Group and the Policy Development team;

                                Avenues for funding and coordinating in silico Research, Liesbet Geris, VPHi, Leader of the Research & Technology Working Group

                                 and the Research and Technology team.

           

17:15 - 18:15        Round Table

                               The Avicenna Alliance Board will answer your question and openly discuss key obstacles, opportunities, progress and achievements in

                               front of us 

18:15 - 18:30        Wrap up

                               Thierry Marchal, Secretary General, Avicenna Alliance

    

Wednesday 16° February 2022

Time: 14.00 – 17:30 CEST / 13.00 - 16.30 BST / 17.30 - 21.00 IST / 8.00 - 11.30 EDT / 7.00 - 10.30 CDT

    

14:00 - 14:05        Welcome & Introduction

                               Thierry Marchal, Secretary General, Avicenna Alliance

    

14:05 - 16:05        Regulatory Affairs Forum

                               Moderators:

                               Liesbet Geris, VPHi, Leader of the Research & Technology Working Group

                               Francesco Pappalardo, University of Catania, Chair of the Pharmaceutical Task Force

                               Cécile Rousseau, VCLS, Key member of the Avicenna Alliance

                               Marc Horner, Ansys, Leader of the Global Harmonization Task Force

    

16:05 - 16:15       BREAK

 

16:15 - 17:15       Regulatory Affairs Forum

        

17:15 - 17:30       Wrap up

                              Thierry Marchal, Secretary General, Avicenna Alliance

 

 

Avicenna Alliance news

EU-funded project successfully develops AI software that grows and treats cancerous tumors 

The Horizon Europe 2020 project EVO-NANO (Evolvable platform for programmable nanoparticle-based cancer...

find out more ›

In silico used to validate Omicron variant detection method! 

The Joint Research Centre (JRC) has developed a new method to detect the Omicron variant of COVID-19, which differs in its nucleic acid...

find out more ›

The priorities of the upcoming French Presidency of the Council of the European Union - what’s new for Avicenna? 

The French Presidency of the Council of the European Union is due to start on 1...

find out more ›

In Silico in Innovation – again!

The European Innovation Council (EIC) has released its second wave of “start-up champions” to receive funding for innovations through the EIC Accelerator. The EIC...

find out more ›

Avicenna Alliance meets with MEPs to discuss in silico medicine

On 7 October, Dr. Liesbet Geris (Research Professor in Biomechanics and Computational Tissue Engineering at the Universities of Liège &...

find out more ›

The Joint Research Centre advocates for a “paradigm change” to in silico research methods!

For the second week in a row, the Joint Research Centre (JRC) – part of the European Commission’s EU Science...

find out more ›

The European Commission Joint Research Centre publishes a public knowledge base of non-animal models used in immuno-oncology

The Joint Research Centre (JRC), which is part of the European...

find out more ›

The State of the (European) Union

On 15 September, Commission President Ursula von der Leyen delivered her second State of the Union speech at the European Parliament in Strasbourg. She took stock of...

find out more ›

The BECA Beat 

The European Parliament’s Special Committee on Beating Cancer (BECA) met for the first time in September of 2020. BECA was established to create actionable recommendations for Member...

find out more ›

Avicenna Alliance prepares for the next EU policy session 

As September begins, politicians have returned to their EU posts and are preparing for what will be a busy few months for health policy. The...

find out more ›

Joint Research Centre of the Commission launches report on national strategies for Artificial Intelligence!

The Joint Research Centre of the European Commission (JRC) recently published a new report...

find out more ›

Conference of the Slovenian Council Presidency addresses digital twin technologies and digitalisation in healthcare!

On 15 and 16 July, the Slovenian Presidency of the Council of the European Union ...

find out more ›

WHO issues first global report on use of AI in healthcare

Artificial Intelligence (AI) applications in health innovation are rapidly increasing, reflecting the potential of these technologies to...

find out more ›

Slovenian Presidency of the Council of the EU launches its six-month programme!

On 1 July, for the second time since joining the EU in 2004, Slovenia has taken over the Presidency of the Council of...

find out more ›

Members of the European Parliament call EU Health Commissioner to place in silico medicine on her policy agenda from 2021 onwards!

On 22 June, a group of five Members of the European Parliament...

find out more ›

Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

The Avicenna Alliance is proud to announce the recent publication of its new position paper...

find out more ›

Happy 5th Anniversary to the Avicenna Alliance!  

5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

find out more ›

EU New Medical Device Regulation now in force! In silico mentioned for the first time

After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

find out more ›

The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

On 18 May, the European Commission adopted a Communication on its global approach...

find out more ›

Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

On 27 April, the Avicenna Alliance has submitted its feedback...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up